中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性脾血管肉瘤1例报告

王慧君 牛剑祥 徐晓艳 郑卫华 李朋飞 刘一博 张俊晶

王慧君,牛剑祥,徐晓艳,等. 原发性脾血管肉瘤1例报告[J]. 临床肝胆病杂志, 2021, 37(11): 2655-2657. DOI: 10.3969/j.issn.1001-5256.2021.11.036
引用本文: 王慧君,牛剑祥,徐晓艳,等. 原发性脾血管肉瘤1例报告[J]. 临床肝胆病杂志, 2021, 37(11): 2655-2657. DOI: 10.3969/j.issn.1001-5256.2021.11.036
WANG HJ, NIU JX, XU XY, et al. A case of primary splenic angiosarcoma[J]. J Clin Hepatol, 2021, 37(11): 2655-2657. DOI: 10.3969/j.issn.1001-5256.2021.11.036
Citation: WANG HJ, NIU JX, XU XY, et al. A case of primary splenic angiosarcoma[J]. J Clin Hepatol, 2021, 37(11): 2655-2657. DOI: 10.3969/j.issn.1001-5256.2021.11.036

原发性脾血管肉瘤1例报告

DOI: 10.3969/j.issn.1001-5256.2021.11.036
基金项目: 

内蒙古自治区草原英才培养专项基金资助项目 CYYC2012040

详细信息
    通讯作者:

    张俊晶,zhang.jj@vip.163.com

  • 中图分类号: R733.2

A case of primary splenic angiosarcoma

Research funding: 

Inner Mongolia Autonomous Region Grassland Talent Cultivation Special Fund Project CYYC2012040

  • 图  1  术前全腹增强CT检查结果

    注:门静脉期见肝脾内弥漫分布小结节状低强化影,周围见液体密度影。

    图  2  骨髓穿刺病理学检查结果

    注:a,HE染色(×400);b,骨髓见梭形细胞,稍有异型,可见血管腔隙,CD34(+)(免疫组化,×400)。

    图  3  术中腔镜视野

    图  4  术后病理学检查结果

    注:a,脾内未见皮质、髓质结构,可见残存脾小梁(蓝色箭头),视野中见大量增生的肿瘤细胞,多排列为裂隙样,部分见坏死(红色箭头) (HE染色,×100);b,分化较好部位,肿瘤细胞有一定异型性,部分呈鞋钉样,可见血管腔隙(HE染色,×400);c:分化较差部位肿瘤细胞呈梭形,有一定异型性,呈束状、片状排列,可见裂隙,其内可见一脾小动脉(红色箭头)(HE染色,×400);d:Ki-67热点区域(15%+)(免疫组化,×400);e:肿瘤细胞弥漫CD31(+)(免疫组化,×400);f:肿瘤细胞弥漫FLi1 (+)(免疫组化,×400)。

  • [1] LI R, LI M, ZHANG LF, et al. Clinical characteristics and prognostic factors of primary splenic angiosarcoma: A retrospective clinical analysis from China[J]. Cell Physiol Biochem, 2018, 49(5): 1959-1969. DOI: 10.1159/000493656.
    [2] ZHANG ZY, CHENG YJ, GONG XL, et al. Characteristics and outcomes of primary angiosarcoma[J]. Chin J Oncol, 2019, 41(9): 693-697. DOI: 10.3760/cma.j.issn.02533766.2019.09.009.

    张智旸, 程月鹃, 公小蕾, 等. 原发性血管肉瘤的临床特征和预后分析[J]. 中华肿瘤杂志, 2019, 41(9): 693-697. DOI: 10.3760/cma.j.issn.02533766.2019.09.009.
    [3] CAO L, HONG J, WANG Y, et al. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile[J]. Medicine (Baltimore), 2019, 98(28): e16245. DOI: 10.1097/MD.0000000000016245.
    [4] YANG KF, LI Y, WANG DL, et al. Primary splenic angiosarcoma with liver metastasis: A case report and literature review[J]. World J Gastroenterol, 2016, 22(12): 3506-3510. DOI: 10.3748/wjg.v22.i12.3506.
    [5] BATOULI A, FAIRBROTHER SW, SILVERMAN JF, et al. Primary splenic angiosarcoma: Clinical and imaging manifestations of this rare aggressive neoplasm[J]. Curr Probl Diagn Radiol, 2016, 45(4): 284-287. DOI: 10.1067/j.cpradiol.2015.07.004.
    [6] CHEN F, JIN HF, FAN YH, et al. Case report of primary splenic angiosarcoma with hepatic metastases[J]. World J Gastroenterol, 2015, 21(39): 11199-11204. DOI: 10.3748/wjg.v21.i39.11199.
    [7] DENG R, CHANG W, WU X, et al. Primary splenic angiosarcoma with fever and anemia: A case report and literature review[J]. Int J Clin Exp Pathol, 2015, 8(11): 14040-14044.
    [8] MYOTERI D, DESPOINA M, DELLAPORTAS D, et al. Primary angiosarcoma of the spleen: An oncological enigma[J]. Case Rep Oncol Med, 2014, 2014: 193036. DOI: 10.1155/2014/193036.
    [9] CHEN X, LI H, WANG F, et al. Early detection and integral resection are keys to extend survival in patients suffered from primary angiosarcoma of the spleen: A care-compliant case report and literature review[J]. Medicine (Baltimore), 2018, 97(5): e9718. DOI: 10.1097/MD.0000000000009718.
    [10] THIPPHAVONG S, DUIGENAN S, SCHINDERA ST, et al. Nonneoplastic, benign, and malignant splenic diseases: Cross-sectional imaging findings and rare disease entities[J]. AJR Am J Roentgenol, 2014, 203(2): 315-322. DOI: 10.2214/AJR.13.11777.
    [11] THOMPSON WM, LEVY AD, AGUILERA NS, et al. Angiosarcoma of the spleen: Imaging characteristics in 12 patients[J]. Radiology, 2005, 235(1): 106-115. DOI: 10.1148/radiol.2351040308.
    [12] LI H, ZHOU ZQ, LIU B, et al. A case of primary splenic angiosarcoma[J]. Chin J Pathol, 2003, 32(4): 91. DOI: 10.3760/j.issn:0529-5807.2003.04.026.

    李红, 周志强, 刘滨, 等. 原发性脾脏血管肉瘤一例[J]. 中华病理学杂志, 2003, 32(4): 91. DOI: 10.3760/j.issn:0529-5807.2003.04.026.
    [13] CHEN M, ZHA YF, WANG YY, et al. CT findings of primary splenic angiosarcoma and literature review[J]. J Pract Radiol, 2019, 35(1): 159-161. DOI: 10.3969/j.issn.1002-1671.2019.01.041.

    陈明, 查云飞, 王艳艳, 等. 原发性脾血管肉瘤CT表现并文献复习[J]. 实用放射学杂志, 2019, 35(1): 159-161. DOI: 10.3969/j.issn.1002-1671.2019.01.041.
    [14] SILECCHIA G, BORU CE, FANTINI A, et al. Laparoscopic splenectomy in the management of benign and malignant hematologic diseases[J]. JSLS, 2006, 10(2): 199-205.
    [15] de AZEVEDO OS, do NASCIMENTO SANTOS B, de SOUZA LIBONI N, et al. Splenic angiosarcoma: A diagnostic splenectomy finding[J]. Case Rep Oncol, 2016, 9(3): 733-737. DOI: 10.1159/000452619.
    [16] HARA T, TSURUMI H, KASAHARA S, et al. Long-term survival of a patient with splenic angiosarcoma after resection, high-dose chemotherapy, and autologous peripheral blood stem cell transplantation[J]. Intern Med, 2010, 49(20): 2253-2257. DOI: 10.2169/internalmedicine.49.3969.
    [17] VAKKALANKA B, MILHEM M. Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: A brief report and literature review[J]. Clin Med Insights Oncol, 2010, 4: 107-110. DOI: 10.4137/CMO.S5329.
    [18] RUPOLO M, BERRETTA M, BUONADONNA A, et al. Metastatic angiosarcoma of the spleen. A case report and treatment approach[J]. Tumori, 2001, 87(6): 439-443. DOI: 10.1159/000050642.
    [19] ALEXANDRINO H, JULIÃO MJ, TRALHVÃO JG, et al. Rupture of splenic angiosarcoma: A rare cause of spontaneous haemoperitoneum[J]. BMJ Case Rep, 2013, 2013: bcr2013009748. DOI: 10.1136/bcr-2013-009748.
    [20] ASMANE I, LITIQUE V, HEYMANN S, et al. Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literature[J]. Anticancer Res, 2008, 28(5B): 3041-3045. DOI: 10.1097/CAD.0b013e32830c2380.
    [21] LIST AF. Lenalidomide-the phoenix rises[J]. N Engl J Med, 2007, 357(21): 2183-2186. DOI: 10.1056/NEJMe078203.
    [22] CLIFFORD CA, MACKIN AJ, HENRY CJ. Treatment of canine hemangiosarcoma: 2000 and beyond[J]. J Vet Intern Med, 2000, 14(5): 479-485. DOI: 10.1892/0891-6640(2000)014<0479:tochab>2.3.co;2.
    [23] NAKA N, OHSAWA M, TOMITA Y, et al. Prognostic factors in angiosarcoma: A multivariate analysis of 55 cases[J]. J Surg Oncol, 1996, 61(3): 170-176. DOI: 10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8.
    [24] HSU JT, UENG SH, HWANG TL, et al. Primary angiosarcoma of the spleen in a child with long-term survival[J]. Pediatr Surg Int, 2007, 23(8): 807-810. DOI: 10.1007/s00383-007-1874-1.
  • 加载中
图(4)
计量
  • 文章访问数:  37
  • HTML全文浏览量:  13
  • PDF下载量:  17
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-03-30
  • 修回日期:  2021-05-06
  • 网络出版日期:  2021-11-16
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回